NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics 1 Year Total Returns (Daily): -86.42% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -86.42% |
May 15, 2024 | -86.42% |
May 14, 2024 | -85.49% |
May 13, 2024 | -86.49% |
May 10, 2024 | -89.03% |
May 09, 2024 | -88.68% |
May 08, 2024 | -89.66% |
May 07, 2024 | -89.86% |
May 06, 2024 | -90.14% |
May 03, 2024 | -89.70% |
May 02, 2024 | -90.22% |
May 01, 2024 | -89.54% |
April 30, 2024 | -89.50% |
April 29, 2024 | -89.35% |
April 26, 2024 | -90.60% |
April 25, 2024 | -90.87% |
April 24, 2024 | -91.38% |
April 23, 2024 | -91.43% |
April 22, 2024 | -91.45% |
April 19, 2024 | -91.21% |
April 18, 2024 | -91.12% |
April 17, 2024 | -91.10% |
April 16, 2024 | -91.22% |
April 15, 2024 | -90.93% |
April 12, 2024 | -90.09% |
Date | Value |
---|---|
April 11, 2024 | -89.69% |
April 10, 2024 | -89.61% |
April 09, 2024 | -90.05% |
April 08, 2024 | -90.63% |
April 05, 2024 | -90.83% |
April 04, 2024 | -89.72% |
April 03, 2024 | -89.04% |
April 02, 2024 | -88.43% |
April 01, 2024 | -88.66% |
March 28, 2024 | -86.96% |
March 27, 2024 | -87.86% |
March 26, 2024 | -86.15% |
March 25, 2024 | -86.89% |
March 22, 2024 | -86.67% |
March 21, 2024 | -87.60% |
March 20, 2024 | -89.36% |
March 19, 2024 | -82.04% |
March 18, 2024 | -82.01% |
March 15, 2024 | -79.26% |
March 14, 2024 | -79.07% |
March 13, 2024 | -78.93% |
March 12, 2024 | -78.71% |
March 11, 2024 | -76.17% |
March 08, 2024 | -79.45% |
March 07, 2024 | -79.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.45%
Minimum
Apr 22 2024
207.2%
Maximum
Jul 26 2023
-25.20%
Average
-60.84%
Median
Jan 05 2024
1 Year Total Returns (Daily) Benchmarks
AC Immune SA | 58.60% |
CRISPR Therapeutics AG | -9.77% |
Addex Therapeutics Ltd | -41.80% |
Molecular Partners AG | -43.77% |
MoonLake Immunotherapeutics | 51.56% |